bioAffinity Technologies Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for bioAffinity Technologies, Inc. (BIAF) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents1.112.8211.411.360.08
Cash & Short-Term Investments1.112.8211.411.360.08
Accounts Receivable1.140.780.010.000.00
Inventory0.030.020.010.000.00
Other Current Assets0.250.150.190.060.01
Total Current Assets2.703.9711.961.440.12
Non-Current Assets
Property, Plant & Equipment (Net)1.621.990.210.000.01
Goodwill1.401.400.000.000.00
Intangible Assets0.780.830.000.000.00
Other Non-Current Assets0.020.020.010.000.02
Total Non-Current Assets3.824.250.220.020.00
Total Assets6.518.2212.181.450.15
Current Liabilities
Accounts Payable0.990.600.350.230.19
Short-Term Debt0.170.000.2511.200.19
Current Portion of Long-Term Debt0.170.000.000.050.19
Accrued Liabilities1.400.290.201.330.98
Deferred Revenue0.020.030.000.000.00
Other Current Liabilities1.400.000.340.000.00
Total Current Liabilities3.102.251.1413.0411.12
Non-Current Liabilities
Long-Term Debt0.021.120.000.160.05
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.811.120.004.200.00
Total Liabilities3.913.371.1417.2411.17
Stockholders' Equity
Common Stock0.110.070.060.020.02
Retained Earnings-53.64-44.60-36.67-28.51-22.19
Additional Paid-in Capital56.1449.3947.6512.700.00
Shares Outstanding0.520.310.280.090.00
Total Stockholders' Equity2.604.8611.04-15.79-11.03
Total Liabilities & Equity6.518.2212.181.450.00